Life sciences can be a challenging business, but the rewards of improving patients’ lives are unparalleled. EisnerAmper’s Life Sciences practice exists to offer innovators and entrepreneurs the expertise, resources and relationships they need to bridge the gaps between creativity, funding needs, and commercial success.
From New York to San Francisco to Boston, EisnerAmper serves pharmaceutical, biotechnology and medical device clients, as well as other companies operating at the intersection of technology, health care and life sciences.
We offer a comprehensive suite of accounting and audit, valuation, tax, and advisory services, geared to every stage of our client’s development cycle. For more mature and growing companies, we also provide transaction advisory services to prepare for or conduct due diligence. Our life sciences team is particularly well-versed in the mechanics of growth capital, and many clients rely on us to refer them to qualified investors and lenders at every stage of funding. EisnerAmper clients have participated in a number of significant exit events, including mergers and acquisitions and dozens of initial public offerings. Additional service offerings include:
- business and strategic plans
- technology tax credits and programs
- revenue recognition issues
- government contracting services and A-133 audits
- stock-based compensation structures
- IPO preparedness
- net operating loss/R&D credit planning and evaluation
- start-up services (CFO outsourcing, tax structuring, etc.)
- royalty and contract compliance audits
At EisnerAmper, our approach focuses on a collaborative relationship with company founders and management, delivered in a real time environment. In some cases, we have acted as repeat accountants and advisors for serial entrepreneurs. For founders or key members of the C-suite, we are both objective professionals and a trusted sounding board.
Because entrepreneurial success depends to an unusual degree on personal networks, our practice professionals are well-connected in regional biotechnology and life science ecosystems. Clients benefit from EisnerAmper’s active involvement in and support of organizations such as BIO, BioNJ and PennsylvaniaBio, and affiliations with leading academic entities such as New York University.